SCHEMBL20874037

SCHEMBL20874037

C[C@H]1CN(c2ccc(N)cc2Cl)CCN1C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.52
▸ HTT P42858 1/20 0.52
▸ MAPT P10636 7/20 0.50
▸ KDM4E B2RXH2 2/20 0.50
▸ RAD52 P43351 1/20 0.50
▸ POLB P06746 1/20 0.47
▸ GAA P10253 3/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ RECQL P46063 1/20 0.43
▸ NOTUM Q6P988 1/20 0.42
▸ BRD4 O60885 1/20 0.42
▸ SMARCA2 P51531 1/20 0.42
▸ SMARCA4 P51532 1/20 0.42
▸ PBRM1 Q86U86 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.40
▸ GFER P55789 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ HSD11B1 P28845 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20874039 1.00 ALDH1A1 (0.52) ALDH1A1HTTMAPTKDM4ERAD52
SCHEMBL20874085 1.00 ALDH1A1 (0.52) ALDH1A1HTTMAPTKDM4ERAD52
SCHEMBL20874064 0.86 MAPT (0.53) ALDH1A1MAPTGAABRD4SMARCA2
SCHEMBL28094549 0.86 MAPT (0.53) ALDH1A1MAPTGAABRD4SMARCA2
SCHEMBL23291446 0.84 HSD11B1 (0.47) ALDH1A1HTTMAPTKDM4ESMN1; SMN2
SCHEMBL20874055 0.83 MAP4K4 (0.51) ALDH1A1HTTMAPTKDM4ERAD52
SCHEMBL20884865 0.83 MAP4K4 (0.51) ALDH1A1HTTMAPTKDM4ERAD52
SCHEMBL20884630 0.83 MAP4K4 (0.51) ALDH1A1HTTMAPTKDM4ERAD52
SCHEMBL16825000 0.79 GFER (0.50) ALDH1A1HTTMAPTKDM4ERAD52
SCHEMBL18040024 0.79 GFER (0.50) ALDH1A1HTTMAPTKDM4ERAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10807994-B2 Heterocyclic compounds and uses thereof NUVATION BIO INC. (US) 2020-10-20 — — US disclosed
US-20190106436-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF SAGARD HOLDINGS MANAGER LP, AS ADMINISTRATIVE AGENT (CA) 2019-04-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190106436-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF WEE1, WEE2, NME1 ALDH1A1 2869/4885HTT 2861/4885MAPT 4445/4885
US-10807994-B2 Heterocyclic compounds and uses thereof WEE1, WEE2, CCNE1 ALDH1A1 1113/4885HTT 3982/4885MAPT 4642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback